Establishment Labs Completes Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Terri Ross Consulting has introduced a Fractional CFO Advisory Service for medical aesthetic practices and appointed Emily Brems to lead the new division, expanding its financial oversight offerings for growing practices.